{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:11:02Z","timestamp":1778343062918,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"DOI":"10.7759\/cureus.108553","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:41:10Z","timestamp":1778341270000},"source":"Crossref","is-referenced-by-count":0,"title":["Reassessment of Long-Term Guideline-Directed Therapy for Peripheral Arterial Occlusive Disease in Primary Care"],"prefix":"10.7759","author":[{"given":"Joomong","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000471","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman MD","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, et al.. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017, 135:e726-e779. 10.1161\/CIR.0000000000000471","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/Aacvpr\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guideline","volume":"83","author":"Gornik HL","year":"2024","unstructured":"Gornik HL, Aronow HD, Goodney PP, et al.. 2024 ACC\/AHA\/Aacvpr\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guideline. J Am Coll Cardiol. 2024, 83:2497-2604. 10.1016\/j.jacc.2024.02.013","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch AT","year":"2001","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D, et al.. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001, 286:1317-1324. 10.1001\/jama.286.11.1317","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02869-2","article-title":"Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication","volume":"90","author":"Thompson PD","year":"2002","unstructured":"Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002, 90:1314-1319. 10.1016\/S0002-9149(02)02869-2","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson DL","year":"2000","unstructured":"Dawson DL, Cutler BS, Hiatt WR, et al.. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000, 109:523-530. 10.1016\/S0002-9343(00)00569-6","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet. 1996, 348:1329-1339. 10.1016\/S0140-6736(96)09457-3","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler ER III","year":"2003","unstructured":"Mohler ER III, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003, 108:1481-1486. 10.1161\/01.CIR.0000090686.57897.F5","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann DM","year":"2010","unstructured":"Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010, 44:1410-1421. 10.1345\/aph.1P150","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.08.017","article-title":"Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"33","author":"Gandhi S","year":"2017","unstructured":"Gandhi S, Chen S, Hong L, et al.. Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Can J Cardiol. 2017, 33:219-231. 10.1016\/j.cjca.2016.08.017","journal-title":"Can J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492550-reassessment-of-long-term-guideline-directed-therapy-for-peripheral-arterial-occlusive-disease-in-primary-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:41:12Z","timestamp":1778341272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492550-reassessment-of-long-term-guideline-directed-therapy-for-peripheral-arterial-occlusive-disease-in-primary-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.108553","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}